Welcome to our dedicated page for Blade Air Mobility news (Ticker: BLDE), a resource for investors and traders seeking the latest updates and insights on Blade Air Mobility stock.
Track breaking news and developments related to Blade Air Mobility Inc. (BLDE), which has undergone a significant corporate transformation. The company divested its passenger aviation business and rebranded as Strata Critical Medical, Inc., now trading under ticker symbol SRTA.
Historical news coverage of BLDE reflects the company's evolution from a dual-business model operating both passenger aviation services and medical logistics operations. The passenger division provided helicopter flights, seaplane services, and jet charter across urban markets in the United States and Europe. The medical logistics segment specialized in time-critical organ transport for transplant hospitals and organ procurement organizations nationwide.
Following the strategic divestiture to Joby Aviation, the company completed its transformation into a pure-play medical logistics provider. News developments now focus on the SRTA ticker symbol, which represents the successor entity operating one of the nation's largest dedicated organ transport networks. Coverage includes partnerships with transplant hospitals, service expansion initiatives, technological innovations in logistics coordination, and financial performance of the medical-focused business model.
The passenger aviation assets and Blade consumer brand transferred to Joby Aviation as part of the separation transaction. Investors and analysts seeking current operational updates, strategic initiatives, and financial results should reference news coverage under the SRTA ticker symbol, as BLDE no longer represents an actively traded security.
Blade Air Mobility (Nasdaq: BLDE) announced its participation in two upcoming investor conferences. The company will take part in the Bank of America Transportation, Airlines, and Industrials Conference on May 16, 2024, where CEO Rob Wiesenthal will join a fireside chat at 8:45 AM ET. Additionally, Blade will participate in the J.P. Morgan 52nd Annual Global Technology, Media, and Communications Conference on May 21, 2024, with CFO Will Heyburn featured in a fireside chat at 5:05 PM ET. Webcasts of both events will be available online.
Blade Air Mobility reported strong financial results for the first quarter ended March 31, 2024. The company achieved record-high Medical revenue of $36.0 million, a 34.6% increase from the prior year. Net loss improved by $6.0 million to $(4.2) million. Adjusted EBITDA also improved significantly. Blade confirmed guidance for Adjusted EBITDA profitability in 2024 and double-digit millions for 2025.
FAQ
What is the current stock price of Blade Air Mobility (BLDE)?
What is the market cap of Blade Air Mobility (BLDE)?
